Angimmune

Angimmune is a biotechnology company focused on researching the role of immunotoxins in the treatment of T-cell related diseases, including blood and skin cancers and certain autoimmune disorders. It provides a high potency fusion protein anticancer immunotoxin Resimmune that can be used to induce anti-tumor CD8+ central memory T cell expansion following T cell depletion during homeostatic proliferation.